Blueprint Medicines Corp buy BiotechBee
Start price
07.09.22
/
60%
€74.46
Target price
31.12.24
€100.00
Performance (%)
-29.49%
End price
05.05.23
€52.50
Summary
This prediction ended on 05.05.23 with a price of €52.50. The prediction for Blueprint Medicines Corp disappointed with a performance of -29.49%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Blueprint Medicines Corp | - | - | - | - |
| iShares Core DAX® | -2,12 % | -8,18 % | -1,47 % | 54,14 % |
| iShares Nasdaq 100 | -1,13 % | 0,91 % | 19,96 % | 83,32 % |
| iShares Nikkei 225® | -0,66 % | -6,26 % | 27,47 % | 53,61 % |
| iShares S&P 500 | -1,26 % | -1,00 % | 13,63 % | 62,62 % |
According to BiotechBee what are the pros and cons of Blueprint Medicines Corp for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Blueprint Medicines Corp diskutieren
Buy mit Kursziel 100,0